What is a stock summary page? Click here for an overview.
Business Description
Organovo Holdings Inc
NAICS : 541714
SIC : 2836
ISIN : US68620A1043
Description
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.1 | |||||
| Equity-to-Asset | 0.1 | |||||
| Debt-to-Equity | 2.91 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -137.22 | |||||
| Beneish M-Score | -5.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 12.7 | |||||
| 3-Year EPS without NRI Growth Rate | 13.1 | |||||
| 3-Year FCF Growth Rate | 6.9 | |||||
| 3-Year Book Growth Rate | -57.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 60.59 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 27.55 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.86 | |||||
| 9-Day RSI | 30.68 | |||||
| 14-Day RSI | 37.71 | |||||
| 3-1 Month Momentum % | 95.15 | |||||
| 6-1 Month Momentum % | 48.47 | |||||
| 12-1 Month Momentum % | -34.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.72 | |||||
| Quick Ratio | 0.72 | |||||
| Cash Ratio | 0.4 | |||||
| Days Inventory | 32728.33 | |||||
| Days Sales Outstanding | 101.12 | |||||
| Days Payable | 52063.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.1 | |||||
| Shareholder Yield % | -120.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 95.9 | |||||
| Operating Margin % | -10293.44 | |||||
| Net Margin % | -10151.64 | |||||
| FCF Margin % | -8276.23 | |||||
| ROE % | -302.24 | |||||
| ROA % | -175.43 | |||||
| ROIC % | -380.44 | |||||
| 3-Year ROIIC % | 139.77 | |||||
| ROC (Joel Greenblatt) % | -717.11 | |||||
| ROCE % | -264.8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 23.4 | |||||
| PB Ratio | 9.45 | |||||
| Price-to-Tangible-Book | 9.34 | |||||
| EV-to-EBIT | -0.33 | |||||
| EV-to-EBITDA | -0.34 | |||||
| EV-to-Revenue | 34.73 | |||||
| EV-to-Forward-Revenue | 31.92 | |||||
| EV-to-FCF | -0.42 | |||||
| Price-to-GF-Value | 1.13 | |||||
| Earnings Yield (Greenblatt) % | -303.03 | |||||
| FCF Yield % | -232.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Organovo Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.122 | ||
| EPS (TTM) ($) | -10.2 | ||
| Beta | 2.56 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 104.61 | ||
| 14-Day RSI | 37.71 | ||
| 14-Day ATR ($) | 0.719051 | ||
| 20-Day SMA ($) | 4.69995 | ||
| 12-1 Month Momentum % | -34.45 | ||
| 52-Week Range ($) | 3.0744 - 22.08 | ||
| Shares Outstanding (Mil) | 1.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Organovo Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Organovo Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Organovo Holdings Inc Frequently Asked Questions
What is Organovo Holdings Inc(LTS:0R02)'s stock price today?
The current price of LTS:0R02 is $3.17. The 52 week high of LTS:0R02 is $22.08 and 52 week low is $3.07.
When is next earnings date of Organovo Holdings Inc(LTS:0R02)?
The next earnings date of Organovo Holdings Inc(LTS:0R02) is 2025-05-19 Est..
Does Organovo Holdings Inc(LTS:0R02) pay dividends? If so, how much?
Organovo Holdings Inc(LTS:0R02) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers